Searched for
ERIS LIFESCIENCES NEWS
Natco Pharma, Eris Lifesciences shares jump up to 6% on partnership for Semaglutide launch in IndiaShares of Natco Pharma and Eris Lifesciences climbed on Tuesday after announcing a partnership to commercialise Semaglutide in India. Natco...
Eris Lifesciences shares in focus on move to acquire Swiss Parenterals in Rs 423 crore dealEris Lifesciences is set to fully acquire its injectable unit, Swiss Parenterals. The deal involves a share swap valued at Rs 423.3 crore. ...
Eris Lifesciences' unit gets Brazil health regulator nodEris Lifesciences announced that its Ahmedabad manufacturing facility secured approval from ANVISA, Brazil's health regulatory agency, foll...
Stocks in news: IndiGo, Apollo Hospitals, Hyundai, TCS, NMDC, Laurus LabsApollo Hospitals' Hyderabad-based arm Apollo Health and Lifestyle Limited (AHLL) has acquired a controlling stake in Lucknow-based Care Dia...
Breakout Stocks: How to trade Vedanta, Swan Energy and Eris Lifesciences on ThursdayIndian markets closed flat with gains in auto, FMCG, and IT. Vedanta, near its 52-week high, offers a new entry point. Swan Energy is recom...
Buy Eris Lifesciences, target price Rs 1100: Prabhudas LilladherEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
Eris Lifesciences Q4 Results: Net profit jumps over 29% to Rs 80 croreThe Ahmedabad-based drug maker reported a net profit of Rs 61.5 crore during the corresponding quarter of the previous year. Revenue of Q4F...
Neutral on Eris Lifesciences, target price Rs 930: Motilal OswalEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
Buy Eris Lifesciences, target price Rs 1070: HDFC SecuritiesEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
Buy Eris Lifesciences, target price Rs 1050: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 12633.84 Crore) operating in Pharmac...
Stocks in news: IndusInd Bank, ITC, ICICI Pru Life, Rail Vikas, Delta Corp, Glenmark PharmaIndusInd Bank will report its earnings for the December quarter on Wednesday. The bank is expected to report strong growth in income on the...
Buy Eris Lifesciences, target price Rs 825: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 9395.71 Crore) operating in Pharmace...
Buy Eris Lifesciences, target price Rs 850: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8921.10 Crore) operating in Pharmace...
Market Movers: Resurgent Covid brings tailwinds for healthcare stocksShares of healthcare stocks – pharma companies and diagnostic companies – jumped in trade today as the government got into battle mode to s...
Eris Lifesciences jumps 10% as investors cheer JV with MJ BiopharmThe JV, dubbed Eris Biopharm, would be in the ratio of 70:30, with Eris holding a 70 per cent stake.
Buy Eris Lifesciences, target price Rs 880: ICICI DirectEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 10371.61 Crore) operating in Pharmac...
Buy Eris Lifesciences, target price Rs 660: Yes SecuritiesEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 8217.45 Crore) operating in Pharmace...
Citigroup maintains buy on Eris Lifesciences, raises target price to Rs 750The brokerage has raised FY21 and FY22 estimated EPS by 2.5% and 3% respectively.
Patni family backed, PlexusMD join hands with Eris Lifesciences for SaarthiSaarthi, the AI-powered learning platform endeavours to enable Indian physicians to stay connected with global developments and practice ev...
Market Now: Nearly 90 stocks hit fresh 52-week low todayOnly Nifty Pharma and IT indices were trading in green.